Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
1.330
-0.070 (-5.00%)
At close: Oct 2, 2026, 4:00 PM EDT
1.340
+0.010 (0.75%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $171.14 million as of October 2, 2026. Its market cap has decreased by -68.18% in one year.
Market Cap
171.14M
Enterprise Value
191.99M
1-Year Change
-68.18%
Ranking
Category
Stock Price
$1.33
ChartMarket Cap Chart
Since January 8, 2019, Organogenesis Holdings's market cap has decreased from $1.24B to $171.14M, a decrease of -86.16%. That is a compound annual growth rate of -22.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 171.14M | -73.97% |
| Dec 31, 2025 | 657.40M | 63.40% |
| Dec 31, 2024 | 402.32M | -25.09% |
| Dec 29, 2023 | 537.07M | 52.51% |
| Dec 30, 2022 | 352.16M | -70.37% |
| Dec 31, 2021 | 1.19B | 23.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioAge Labs | 308.43M |
| Anika Therapeutics | 257.89M |
| Aurora Cannabis | 254.03M |
| Lifecore Biomedical | 247.94M |
| Akebia Therapeutics | 246.40M |
| SIGA Technologies | 239.26M |
| Cardiol Therapeutics | 195.03M |
| Journey Medical | 191.36M |